Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN108484500B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.